Amany E. Ragab
Impact in
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Plant biochemistry and biosynthesis 3
-
- Microbial Natural Products and Biosynthesis 7
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Sabine Grüschow (3 shared papers)Rebecca J. M. Goss (3 shared papers)Lamiaa A. Al-Madboly (4 shared papers)Amal Kabbash (5 shared papers)Doaa H. Assar (4 shared papers)Zizy I. Elbialy (4 shared papers)Abdel‐Rahim S. Ibrahim (6 shared papers)Nehal M. El‐Deeb (1 shared paper)
- Journals
- Pharmaceuticals (3 papers)Scientific Reports (2 papers)Frontiers in Bioengineering and Biotechnology (2 papers)Antioxidants (2 papers)Molecules (2 papers)
- Partner nations
- EgyptSaudi ArabiaUnited Kingdom
In The Last Decade
Amany E. Ragab
34 papers receiving 470 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 98
- Drug Discovery 1
- Biochemistry 32
- Pharmacology 43
- Food Science 78
Countries citing papers authored by Amany E. Ragab
This map shows the geographic impact of Amany E. Ragab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amany E. Ragab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amany E. Ragab more than expected).
Fields of papers citing papers by Amany E. Ragab
This network shows the impact of papers produced by Amany E. Ragab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amany E. Ragab. The network helps show where Amany E. Ragab may publish in the future.
Co-authors
The 25 scholars most cited alongside Amany E. Ragab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 64 | |
| 2 | 2021 | 49 | |
| 3 | 2020 | 41 | |
| 4 | 2021 | 35 | |
| 5 | 2023 | 32 | |
| 6 | 2023 | 26 | |
| 7 | 2011 | 25 | |
| 8 | 2021 | 23 | |
| 9 | 2020 | 20 | |
| 10 | 2023 | 18 | |
| 11 | 2010 | 18 | |
| 12 | 2023 | 17 | |
| 13 | 2022 | 16 | |
| 14 | 2022 | 12 | |
| 15 | 2022 | 9 | |
| 16 | 2023 | 9 | |
| 17 | 2022 | 8 | |
| 18 | 2018 | 7 | |
| 19 | 2022 | 6 | |
| 20 | 2018 | 6 |
About Amany E. Ragab
Amany E. Ragab is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Food Science and Plant Science, having authored 38 papers that have together received 477 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (7 papers), Botany and Geology in Latin America and Caribbean (3 papers), Phytochemicals and Antioxidant Activities (3 papers), Plant biochemistry and biosynthesis (3 papers), Pomegranate: compositions and health benefits (2 papers), Aquaculture Nutrition and Growth (2 papers), Carbohydrate Chemistry and Synthesis (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Pharmacology (98 citations), Drug Discovery (1 citation), Biochemistry (32 citations), Pharmacology (43 citations) and Food Science (78 citations). Amany E. Ragab has collaborated with scholars based in Egypt, Saudi Arabia and United Kingdom. Frequent co-authors include Sabine Grüschow, Rebecca J. M. Goss, Lamiaa A. Al-Madboly, Amal Kabbash, Doaa H. Assar, Zizy I. Elbialy, Abdel‐Rahim S. Ibrahim, Nehal M. El‐Deeb, Manal A. Nael and Ahmed M. Kenawy. Their work appears in journals such as Pharmaceuticals, Scientific Reports, Frontiers in Bioengineering and Biotechnology, Antioxidants and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.